Articles with public access mandates - Christopher E. NelsonLearn more
Not available anywhere: 2
Genome engineering: a new approach to gene therapy for neuromuscular disorders
CE Nelson, JN Robinson-Hamm, CA Gersbach
Nature Reviews Neurology 13 (11), 647-661, 2017
Mandates: US National Science Foundation, US Department of Defense, US National …
Gene delivery into cells and tissues
CE Nelson, CL Duvall, A Prokop, CA Gersbach, JM Davidson
Principles of Tissue Engineering, 519-554, 2020
Mandates: US National Science Foundation, US National Institutes of Health, US …
Available somewhere: 31
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
CE Nelson, CH Hakim, DG Ousterout, PI Thakore, EA Moreb, RMC Rivera, ...
Science 351 (6271), 403-407, 2016
Mandates: US National Science Foundation, US National Institutes of Health, Leducq …
Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs.
BC Evans, CE Nelson, SS Yu, KR Beavers, AJ Kim, H Li, HM Nelson, ...
Journal of visualized experiments: JoVE, 2012
Mandates: US National Institutes of Health
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
CE Nelson, Y Wu, MP Gemberling, ML Oliver, MA Waller, JD Bohning, ...
Nature medicine 25 (3), 427-432, 2019
Mandates: US National Science Foundation, US Department of Defense, US National …
Balancing Cationic and Hydrophobic Content of PEGylated siRNA Polyplexes Enhances Endosome Escape, Stability, Blood Circulation Time, and Bioactivity in Vivo
CE Nelson, JR Kintzing, A Hanna, JM Shannon, MK Gupta, CL Duvall
ACS nano 7 (10), 8870-8880, 2013
Mandates: US National Institutes of Health
ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease
KM Poole, CE Nelson, RV Joshi, JR Martin, MK Gupta, SC Haws, ...
Biomaterials 41, 166-175, 2015
Mandates: US National Institutes of Health
Poly (PS-b-DMA) micelles for reactive oxygen species triggered drug release
MK Gupta, TA Meyer, CE Nelson, CL Duvall
Journal of Controlled Release 162 (3), 591-598, 2012
Mandates: US National Institutes of Health
Tunable Delivery of siRNA from a Biodegradable Scaffold to Promote Angiogenesis In Vivo
CE Nelson, AJ Kim, EJ Adolph, MK Gupta, F Yu, KM Hocking, ...
Advanced Materials 26 (4), 607-614, 2014
Mandates: US National Institutes of Health
Macrophage-Specific RNA Interference Targeting via “Click”, Mannosylated Polymeric Micelles
SS Yu, CM Lau, WJ Barham, HM Onishko, CE Nelson, H Li, CA Smith, ...
Molecular pharmaceutics 10 (3), 975-987, 2013
Mandates: US National Institutes of Health
Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers
M Miteva, KC Kirkbride, KV Kilchrist, TA Werfel, H Li, CE Nelson, ...
Biomaterials 38, 97-107, 2015
Mandates: US National Institutes of Health
RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
PI Thakore, JB Kwon, CE Nelson, DC Rouse, MP Gemberling, ML Oliver, ...
Nature communications 9 (1), 1-9, 2018
Mandates: US National Science Foundation, US National Institutes of Health, American …
Matrix Metalloproteinase Responsive, Proximity‐Activated Polymeric Nanoparticles for siRNA Delivery
H Li, SS Yu, M Miteva, CE Nelson, T Werfel, TD Giorgio, CL Duvall
Advanced Functional Materials 23 (24), 3040-3052, 2013
Mandates: US National Institutes of Health
Engineering Delivery Vehicles for Genome Editing
CE Nelson, CA Gersbach
Annual review of chemical and biomolecular engineering 7, 637-662, 2016
Mandates: US National Institutes of Health
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models
CH Hakim, SRP Kumar, DO Pérez-López, NB Wasala, D Zhang, Y Yue, ...
Nature communications 12 (1), 1-12, 2021
Mandates: US Department of Defense, US National Institutes of Health
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice
CH Hakim, NB Wasala, CE Nelson, LP Wasala, Y Yue, JA Louderman, ...
JCI insight 3 (23), 2018
Mandates: US Department of Defense, US National Institutes of Health
MiRNA inhibition in tissue engineering and regenerative medicine
KR Beavers, CE Nelson, CL Duvall
Advanced drug delivery reviews 88, 123-137, 2015
Mandates: US National Institutes of Health
Technologies for controlled, local delivery of siRNA
SM Sarett, CE Nelson, CL Duvall
Journal of Controlled Release 218, 94-113, 2015
Mandates: US National Institutes of Health
Targeted transcriptional modulation with type I CRISPR–Cas systems in human cells
A Pickar-Oliver, JB Black, MM Lewis, KJ Mutchnick, TS Klann, KA Gilcrest, ...
Nature biotechnology 37 (12), 1493-1501, 2019
Mandates: US National Science Foundation, US National Institutes of Health
Sustained local delivery of siRNA from an injectable scaffold
CE Nelson, MK Gupta, EJ Adolph, JM Shannon, SA Guelcher, CL Duvall
Biomaterials 33 (4), 1154-1161, 2012
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program